JPMorgan raised the firm’s price target on Synovus (SNV) to $60 from $50 and keeps an Overweight rating on the shares as part of a mid- and small-cap banks earnings preview for Q2.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks